University of Virginia Brain Institute and School of Medicine researchers have received an initial $9.3 million award from the National Institutes of Health for a $30 million clinical trial to ...

Neuraxpharm introduced Midazolam buccal as an anti-epileptic drug meant to treat status epilepticus. The buccal mucosal delivery of Midazolam provides a convenient and fast-absorbing method for ...

Investorideas , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Life Sciences and AI sectors ...

Patna: International Epilepsy Day, observed on the second Monday of Feb since 2015, aims to educate the public, break the ...

LIFESTYLE NEWS - The epilepsy treatment gap—the disparity between those in need of treatment and those receiving it—remains ...

Kami Kountcheva | Scientists in the US have received an initial $9.3 million from the National Institutes of Health for a $30 million clinical trial into the use of ketamine for status epilepticus in ...

The National Plan aims to support the 3.4 million people living with epilepsy in the United States through a unified approach ...

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Companies granted Fast Track status are able to have more frequent meetings and written communications with the FDA to discuss the drug's developmental plan, the design of proposed clinical trials ...

In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...

SINGAPORE (Reuters) - Japan's Nissan Motor is open to working with new partners including even technology firms after merger talks with cross-town rival Honda Motor foundered, people familiar with ...